School personnel information

写真b

HOSEN Naoki


Keyword

hematology, oncology, stem cell biology, cancer immunology

Mail Address

Mail Address

Gender

Male

Organization 【 display / non-display

  • 2007.04.01 - 2007.04.30, Division of Health Sciences, Graduate School of Medicine, Specially Appointed Researcher

  • 2007.05.01 - 2009.03.31, Graduate School of Medicine, Associate Professor

  • 2009.04.01 - 2014.03.31, Division of Health Sciences, Graduate School of Medicine, Associate Professor

  • 2014.04.01 - 2019.12.31, Division of Health Sciences, Graduate School of Medicine, Associate Professor

  • 2020.01.01 - , Division of Medicine, Graduate School of Medicine, Professor

Education 【 display / non-display

Osaka University Faculty of Medicine  Graduated 1994.03
Osaka University Graduate School, Division of Medical Sciences  Completed Ph.D 2002.03

Research topics 【 display / non-display

  • Development of novel cancer immunotherapies
    Hematology and medical oncology-related, Tumor diagnostics and therapeutics-related

  • Hematology and medical oncology-related, Experimental pathology-related

 

Academic Papers 【 display / non-display

  • A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma., Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H, Cancer immunology, immunotherapy : CII,68(2) 331-340, 2019.02, Other

  • Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells., Yuhei Kinehara, Izumi Nagatomo, Shohei Koyama, Daisuke Ito, Satoshi Nojima, Ryota Kurebayashi, Yoshimitsu Nakanishi, Yasuhiko Suga, Yu Nishijima-Futami, Akio Osa, Takeshi Nakatani, Yasuhiro Kato, Masayuki Nishide, Yoshitomo Hayama, Masayoshi Higashiguchi, Osamu Morimura, Kotaro Miyake, Sujin Kang, Toshiyuki Minami, Haruhiko Hirata, Kota Iwahori, Takayuki Takimoto, Hyota Takamatsu, Yoshito Takeda, Naoki Hosen, Shigenori Hoshino, Yasushi Shintani, Meinoshin Okumura, Toru Kumagai, Kazumi Nishino, Fumio Imamura, Shin-Ichi Nakatsuka, Takashi Kijima, Hiroshi Kida, Atsushi Kumanogoh, JCI insight,3(24), 2018.12, Papers

  • Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides., Jun Nakata, Hiroko Nakajima, Hiromu Hayashibara, Kanako Imafuku, Soyoko Morimoto, Fumihiro Fujiki, Daisuke Motooka, Daisuke Okuzaki, Kana Hasegawa, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama, Oncotarget,9(89) 36029-36038, 2018.11, Papers

  • Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity., Morimoto S, Fujiki F, Kondo K, Nakajima H, Kobayashi Y, Inatome M, Aoyama N, Nishida Y, Tsuboi A, Oka Y, Nishida S, Nakata J, Hosen N, Oji Y, Sugiyama H., Oncotarget.,9(75) 34132-34141, 2018.09, Papers

  • WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies., Yusuke Oji, Masayoshi Inoue, Yoshito Takeda, Naoki Hosen, Yasushi Shintani, Manabu Kawakami, Takuya Harada, Yui Murakami, Miki Iwai, Mari Fukuda, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Toshiaki Shirakata, Hiroko Nakajima, Kana Hasegawa, Hiroshi Kida, Takashi Kijima, Soyoko Morimoto, Fumihiro Fujiki, Akihiro Tsuboi, Eiichi Morii, Satoshi Morita, Junichi Sakamoto, Atsushi Kumanogoh, Yoshihiro Oka, Meinoshin Okumura, Haruo Sugiyama, International journal of cancer,142(11) 2375-2382, 2018.06, Papers

display all >>